Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2024-05-07 00:00:00 ET · period of report 2024-05-03 · accession 0001765581-24-000042 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-07 | 2024-05-03 | JAZZ | Patil Neena M | EVP, CLO | S - Sale | $109.65 | -5,000 | 36.6K | -12% | -$548.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2024-05-03 | S | D | 5,000 | $109.65 | 36,629 | D | — | — | (F1) Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $109.58 to $109.77. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |